The method depends on a rapid injection that produces a sudden increase in vascular or tissue pressure. That pressure temporarily expands cell membranes, creating conditions that favor entry of genetic material into cells. Both the injected volume and the resulting pressure therefore influence uptake, while excessive values may increase the risk of procedure-related tissue injury and limit clinical translation.
Hydrodynamic gene delivery uses physical forces rather than a viral carrier to promote intracellular uptake. A brief pressure-driven change in the vascular or tissue environment helps genetic material cross into cells, allowing plasmid DNA, RNA, or other nucleic acids to be evaluated without relying on viral vectors. This makes the delivery strategy useful for comparing nonviral approaches in gene therapy research.
Clinical development depends on controlling several linked factors: the tissue or organ targeted, the injected fluid volume, the pressure generated, and the amount of procedure-related injury. These variables affect delivery performance and safety together. Improving tissue targeting while maintaining effective uptake and minimizing injury remains central to moving the approach from animal studies toward clinical use.
A typical evaluation selects a target tissue or organ, prepares the chosen nucleic acid cargo, and delivers it through a rapid fluid injection designed to create the required pressure change. Investigators then examine intracellular uptake or resulting gene expression. This workflow can reveal whether a delivery strategy supports gene-function studies, therapeutic testing, or further development.
The approach can be used to investigate several forms of genetic material, including plasmid DNA, RNA, and other nucleic acids. The choice depends on the research question and the desired evaluation of gene expression or therapeutic activity. Supporting multiple cargo types allows investigators to compare candidate genetic interventions and explore how delivery strategies perform in medical research.
Animal studies commonly use the liver as an organ in which hydrodynamic delivery can support gene expression. This provides a setting for evaluating whether introduced genetic material reaches tissue and produces a measurable biological result. Such studies can help assess gene function, therapeutic candidates, and delivery strategies before researchers address targeting, pressure control, volume, and injury in clinical translation.